<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00564291</url>
  </required_header>
  <id_info>
    <org_study_id>KEK 044/07</org_study_id>
    <nct_id>NCT00564291</nct_id>
  </id_info>
  <brief_title>Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT)</brief_title>
  <official_title>Evaluation of Retinal Structure With High Resolution OCT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sebastian Wolf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Bern</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of different OCT instruments to assess retinal thickness, correlation to
      fluorescein angiography, and visual outcome after therapy with anti-VEGF therapy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparison of different OCT instruments to assess retinal thickness, correlation to
      fluorescein angiography, and visual outcome after therapy with anti-VEGF therapy
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2007</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Integrity of retinal layers</measure>
    <time_frame>End of study</time_frame>
  </primary_outcome>
  <number_of_groups>7</number_of_groups>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Macular Edema</condition>
  <condition>CNV</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Healthy volunteers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>CSME secondary to diabetic retinopathy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>ARMD with CNV before and after therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <description>ARMD atrophic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5</arm_group_label>
    <description>Retinal vein occlusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6</arm_group_label>
    <description>retinitis pigmentosa</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7</arm_group_label>
    <description>vitreoretinal proliferation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Examination with an OCT device</intervention_name>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
    <arm_group_label>5</arm_group_label>
    <arm_group_label>6</arm_group_label>
    <arm_group_label>7</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        healthy subjects and patients with macular diseases
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Macular disease

          -  Healthy subjects
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sebastian Wolf, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bern</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sebastian Wolf, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Bern</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sebastian Wolf, MD, PhD</last_name>
    <email>sebastian.wolf@insel.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dep. Ophthalmology, University Hospital Bern</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian Wolf, MD PhD</last_name>
      <email>sebastian.wolf@insel.ch</email>
    </contact>
    <investigator>
      <last_name>Martin Zinkernagel, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andreas Ebneter, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marion Munk, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik und Poliklinik f√ºr Augenheilkunde, University Bern</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ute Wolf-Schnurrbusch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2007</study_first_submitted>
  <study_first_submitted_qc>November 26, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 27, 2007</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Inselspital, Berne</investigator_affiliation>
    <investigator_full_name>Sebastian Wolf</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>OCT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Edema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

